ORCHARD THERAPEUTICS PLC's ticker is ORTX and the CUSIP is 68570P101. A total of 80 filers reported holding ORCHARD THERAPEUTICS PLC in Q3 2021. The put-call ratio across all filers is 4.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $3,060,000 | -48.1% | 1,330,370 | -0.9% | 0.00% | -100.0% |
| Q2 2021 | $5,895,000 | -39.8% | 1,342,858 | -0.5% | 0.00% | 0.0% |
| Q1 2021 | $9,798,000 | +67.9% | 1,349,531 | -0.1% | 0.00% | 0.0% |
| Q4 2020 | $5,836,000 | -54.1% | 1,350,835 | -56.3% | 0.00% | 0.0% |
| Q3 2020 | $12,713,000 | -56.9% | 3,093,170 | -37.0% | 0.00% | -75.0% |
| Q2 2020 | $29,479,000 | -10.1% | 4,913,115 | +12.8% | 0.00% | -20.0% |
| Q1 2020 | $32,806,000 | -56.4% | 4,356,698 | -20.3% | 0.01% | -50.0% |
| Q4 2019 | $75,205,000 | +27.8% | 5,469,458 | +10.4% | 0.01% | +25.0% |
| Q3 2019 | $58,862,000 | +4.0% | 4,954,677 | +22.4% | 0.01% | 0.0% |
| Q2 2019 | $56,611,000 | +55.9% | 4,046,558 | +99.3% | 0.01% | +60.0% |
| Q1 2019 | $36,309,000 | +20.8% | 2,030,688 | +6.2% | 0.01% | 0.0% |
| Q4 2018 | $30,068,000 | – | 1,911,531 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 4,081,972 | $9,388,000 | 2.74% |
| RA Capital Management | 11,028,722 | $25,366,000 | 0.35% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,949,416 | $15,984,000 | 0.31% |
| Avidity Partners Management LP | 3,836,798 | $8,825,000 | 0.20% |
| Casdin Capital, LLC | 2,575,000 | $5,923,000 | 0.15% |
| Vivo Capital, LLC | 1,325,736 | $3,049,000 | 0.14% |
| Artal Group S.A. | 1,803,858 | $4,149,000 | 0.09% |
| Eversept Partners, LP | 569,581 | $1,310,036 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 374,811 | $862,000 | 0.09% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,078,315 | $2,480,000 | 0.07% |